MYC and cancer: We concluded that both compounds inhibit MYC-dependent transactivation incolon cancer cells, but not in normal intestinal epithelial cells and embryonic stem cells.In vitro assays revealed that both compounds are unstable in the presence ofmicrosomes (Supplementary Fig S7C).